| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/23/2007 | CN1317033C Blood nourishing body building composition and its production method |
| 05/23/2007 | CN1317032C Sheep-goat double lamb agent |
| 05/23/2007 | CN1317031C Efficient mixture preparation for intensifying solid tumor cell chemical therapeutic sensitivity |
| 05/23/2007 | CN1317030C Treatment of dementia and neurodegenerative diseases with intermediate doses of lhrh antagonists |
| 05/23/2007 | CN1317029C Use of bradykinin-b2 receptor antagonists for treating osteoarthrosis |
| 05/22/2007 | USRE39649 polynucleotide for the preparation of a protein known to be valuable feed additives |
| 05/22/2007 | US7220897 Δ4-desaturase genes and uses thereof |
| 05/22/2007 | US7220875 Amino acid derived prodrugs of propofol, compositions and uses thereof |
| 05/22/2007 | US7220853 Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to Grb2 or Crk1 |
| 05/22/2007 | US7220849 Chimeric nucleic acid containing a nucleic acid sequence encoding a propeptide fused to a nucleic acid sequence encoding a vitamin-k dependent protein selected from factor X, factor VII, factor IX, protein C and prothrombin |
| 05/22/2007 | US7220838 Antibodies that specifically bind hedgehog-derived polypeptides |
| 05/22/2007 | US7220837 Factor VII or Factor VIIa polypeptide comprising a modified GLA domain that enhances membrane binding affinity, for therapy of bleeding disorder |
| 05/22/2007 | US7220836 Dried blood factor composition comprising trehalose |
| 05/22/2007 | US7220834 FHIT proteins and nucleic acids and methods based thereon |
| 05/22/2007 | US7220832 Dermacentor variabilis GABA-gated chloride channels |
| 05/22/2007 | US7220829 Cytokine binding domain of cytokine receptors |
| 05/22/2007 | US7220828 Haemopoietin receptor and genetic sequence encoding same |
| 05/22/2007 | US7220827 Compound binding to leukocytes and medicinal composition containing the compound in labeled state as the active ingredient |
| 05/22/2007 | US7220826 HIV immunogen; DNA vaccines; amino acid sequences |
| 05/22/2007 | US7220825 Polypeptide useful for a non-invasive test for inflammatory bowel disease |
| 05/22/2007 | US7220824 cytostatics which have a tumour-specific action as a result of linkage to alpha v beta 3 integrin antagonists via preferred linking units |
| 05/22/2007 | US7220823 A 710 amino acid protein containing 13 transmembrane domains and bearing homology to murine and C. elegans genes containing 12 transmembrane domains |
| 05/22/2007 | US7220822 CD28 mimetics for blocking T cell mediated immune reactions |
| 05/22/2007 | US7220781 Meta-benzamidine derivatives as serine protease inhibitors |
| 05/22/2007 | US7220729 Huntington's Disease Treatment |
| 05/22/2007 | US7220725 Pharmaceutical composition comprising an analgesic peptide and method for treating pain |
| 05/22/2007 | US7220724 Contortrostatin CN and methods for its use in preventing metastasis and other conditions |
| 05/22/2007 | US7220723 Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents |
| 05/22/2007 | US7220722 Lipoprotein-regulating medicants |
| 05/22/2007 | US7220721 Exendin agonist peptides |
| 05/22/2007 | US7220720 Melanin-concentrating hormone analogs |
| 05/22/2007 | US7220719 Using recombinant zinc finger proteins; use in human therapeutic applications such as cancer therapy and altering plant phenotypes, including disease resistance, fruit ripening |
| 05/22/2007 | US7220718 Oral treatment of hemophilia |
| 05/22/2007 | US7220717 Administering formulation comprising polypeptide and muteins; For immunoregulation and/or treatment of inflammation; muteins, |
| 05/22/2007 | US7220583 Pseudomonas avr and hop proteins, their encoding nucleic acids, and use thereof |
| 05/22/2007 | US7220579 Identification of the gene causing the mouse scurfy phenotype and its human ortholog |
| 05/22/2007 | US7220569 Nucleic acids encoding factor X analogues having a modified protease cleavage site |
| 05/22/2007 | US7220558 Bone repair; animal extract in matrix |
| 05/22/2007 | US7220557 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative disorders |
| 05/22/2007 | US7220556 Preparation of factor XIIIa by gene manipulation |
| 05/22/2007 | US7220546 Methods for diagnosing glaucoma and discovering anti-glaucoma drugs |
| 05/22/2007 | US7220545 Peptide fragment of respiratory syncytial virus protein G, immunogenic agent, pharmaceutical composition containing it and preparation method |
| 05/22/2007 | US7220422 In situ adminiatering Clostridium toxin; antiinflammatory agents |
| 05/22/2007 | US7220420 Hepatitis C virus-derived peptides capable of inducing cytotoxic T lymphocyte responses |
| 05/22/2007 | US7220418 Delivery of trefoil peptides |
| 05/22/2007 | US7220413 Administering as wound healing or antiscarring agent for skin; surgery, injuries, fibrosis |
| 05/22/2007 | US7220407 G-CSF therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction |
| 05/22/2007 | US7220402 Alpha-fetoprotein peptides and uses for imaging |
| 05/22/2007 | CA2276694C New fatty acid derivatives |
| 05/22/2007 | CA2242562C Human dnase resistant to actin inhibition |
| 05/22/2007 | CA2241466C Pharmaceutical composition containing angiotensin ii antagonist |
| 05/22/2007 | CA2206736C Aerosol formulations of peptides and proteins |
| 05/22/2007 | CA2205420C Substance mk7634, process for production thereof, and anthelminthic containing said substance |
| 05/22/2007 | CA2182274C Antigenic preparation for treatment or prevention of helicobacter infection |
| 05/22/2007 | CA2162232C Cerebration improver |
| 05/22/2007 | CA2119236C Use of ifn-gamma for the treatment of infections in transplant recipients |
| 05/22/2007 | CA2111645C Fibrinogen fragment e peptides and antibodies thereto |
| 05/22/2007 | CA2110518C Ctla4 receptor, fusion proteins containing it and uses thereof |
| 05/22/2007 | CA2100559C Domains of extracellular region of human platelet derived growth factor receptor polypeptides |
| 05/22/2007 | CA2073045C A human t cell reactive feline protein (trfp) isolated from house dust and uses therefor |
| 05/22/2007 | CA2046802C Compositions containing protease produced by vibrio and method of use in debridement and wound healing |
| 05/18/2007 | WO2007056681A2 Methods for administering hypoglycemic agents |
| 05/18/2007 | WO2007056525A2 High affinity siglec ligands |
| 05/18/2007 | WO2007056511A2 Metal-binding therapeutic peptides |
| 05/18/2007 | WO2007056464A1 Compounds for enzyme inhibition |
| 05/18/2007 | WO2007056457A2 Methods, compositions, and kits for the treatment of medical conditions |
| 05/18/2007 | WO2007056435A2 Dynamin mediated diseases and associated methods and products |
| 05/18/2007 | WO2007056433A2 Methods of treating tissue defects |
| 05/18/2007 | WO2007056362A2 Glucagon analogs exhibiting physiological solubility and stability |
| 05/18/2007 | WO2007056304A2 Mutated forms of ny-eso-1 produced in yeast and uses thereof |
| 05/18/2007 | WO2007056218A2 Heparan sulfate glycosaminoglycan lyase and uses thereof |
| 05/18/2007 | WO2007056201A2 THERAPEUTIC AGENT FOR iNOS GENERATING ILLNESS |
| 05/18/2007 | WO2007056195A2 Surfactant protein-d for prevention and treatment of lung infections and sepsis |
| 05/18/2007 | WO2007056185A2 Process of making ceramic, mineral and metal beads from powder |
| 05/18/2007 | WO2007056161A1 Methods for promoting neurite outgrowth and survival of dopaminergic neurons |
| 05/18/2007 | WO2007056083A2 Biosynthetic polypeptide fusion inhibitors |
| 05/18/2007 | WO2007055992A2 The use of apoptotic cells ex vivo to generate regulatory t cells |
| 05/18/2007 | WO2007055902A1 Immunogenic peptides and methods of use for treating and preventing cancer |
| 05/18/2007 | WO2007055760A2 Protein composition for promoting wound healing and skin regeneration |
| 05/18/2007 | WO2007055743A2 Treatment of obesity and related disorders |
| 05/18/2007 | WO2007055728A1 Treatment of obesity and related disorders |
| 05/18/2007 | WO2007055578A1 Cyclic antimicrobial peptides derived from lactoferrin |
| 05/18/2007 | WO2007055561A1 R-ras activity in vascular regulation |
| 05/18/2007 | WO2007055397A1 Method of treatment for ischemic heart disease |
| 05/18/2007 | WO2007055388A2 Calcium receptor activator |
| 05/18/2007 | WO2007054949A2 Improved variants of pigment epithelium derived factor and uses thereof |
| 05/18/2007 | WO2007054814A1 Inhibitors of parp activity and uses thereof |
| 05/18/2007 | WO2007054658A1 Control of immune responses |
| 05/18/2007 | WO2007054030A1 Polyethylene glycol modifications of thymosin alpha-1 |
| 05/18/2007 | WO2007053952A1 Platelet factor-4 (pf-4) analogs and their use |
| 05/18/2007 | WO2007053946A1 Method of treating diabetes and/or obesity with reduced nausea side effects using an insulinotropic peptide conjugated to albumin |
| 05/18/2007 | WO2007053945A1 Oral anti-microbial composition comprising competence-stimulating peptide |
| 05/18/2007 | WO2007031853A3 Therapeutic combination of hamlet and a hdac inhibitor to treat cancer |
| 05/18/2007 | WO2007031742A3 Products and methods relating to the use of the endoribonuclease kid/pemk |
| 05/18/2007 | WO2007027463A3 Method and system for extracting blood-derived growth factors |
| 05/18/2007 | WO2007022784A3 Liquid factor vii composition |
| 05/18/2007 | WO2007013944A3 Use of truncated cysteine il28 and il29 mutants to treat cancers and autoimmune disorders |
| 05/18/2007 | WO2007008778A3 Formulations for enhanced mucosal delivery of pyy |
| 05/18/2007 | WO2007008069A3 A method for detecting peptides comprising a cross-b structure |
| 05/18/2007 | WO2007007098A3 Promotion of epithelial regeneration |